Innovative Drug Stocks Rise in Early Trading; Zhendong Pharmaceutical Gains Over 8%
On September 18, 2026, the innovative drug sector advanced in early trading. Zhendong Pharmaceutical rose more than 8%, while ACROBiosystems, Hite Biopharma, Bicheng Pharmaceutical, and Chengdu HitGen gained in sympathy. The move lifted a group of Chinese innovative drug developers at the opening of the session.
On September 18, 2026, the innovative drug sector advanced during early trading.
Zhendong Pharmaceutical rose more than 8%, while ACROBiosystems, Hite Biopharma, Bicheng Pharmaceutical, Chengdu HitGen and other stocks followed with gains.